Description
Explore the frontier of metabolic science with our premium Retatrutide 30mg, engineered for advanced research into weight management and metabolic health. As a pioneering triple-agonist (GGG) peptide, Retatrutide acts on three core receptors—GLP-1, GIP, and Glucagon—offering a comprehensive approach to satiety, glucose homeostasis, and energy expenditure.
- Next-Generation Triple-Agonist: Activates GLP-1, GIP, and Glucagon receptors simultaneously for enhanced metabolic modulation.
- Comprehensive Protocol: 30mg potency suitable for 30-day studies exploring significant reduction in body weight and visceral fat.
- High Purity Peptide: Manufactured to strict research standards to ensure consistent study results.
- Enhanced Fat Utilization: Unlike dual agonists, the inclusion of the glucagon receptor pathway specifically allows researchers to study increased energy expenditure.
